AlphaCentric Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128K Buy
335
+24
+8% +$9.33K 0.11% 201
2026
Q2
$124K Buy
+311
New +$88.5K 0.1% 222
2024
Q2
– Sell
-297
Closed -$103K – 238
2024
Q1
$103K Sell
297
-40
-12% -$15.2K 0.06% 187
2023
Q4
$154K Sell
337
-37
-10% -$18.2K 0.1% 133
2023
Q3
$182K Sell
374
-51
-12% -$24K 0.1% 157
2023
Q2
$190K Buy
+425
New +$214K 0.11% 154
2021
Q4
– Sell
-305
Closed -$119K – 245
2021
Q3
$119K Hold
305
– – 0.03% 152
2021
Q2
$135K Buy
305
+38
+14% +$16.6K 0.04% 149
2021
Q1
$112K Sell
267
-9
-3% -$3.59K 0.04% 140
2020
Q4
$113K Buy
+276
New +$115K 0.05% 111

Other funds holding HUM

AlphaCentric Advisors's HUM Position: Q3 2026 in Review

AlphaCentric Advisors increased its Humana (HUM) stake by 7.7% in Q3 2026, buying an estimated $9.33K and bringing the position to 335 shares worth $128K. The position accounts for 0.11% of the portfolio, ranked #201.

AlphaCentric Advisors first reported a position in HUM in Q4 2020 and has held it in 10 quarters since. The position peaked at $190K in Q2 2023. 802 funds tracked by Wall St. Rank hold HUM as of Q3 2026.

  • AlphaCentric Advisors held 335 shares of Humana worth $128K as of Q3 2026.
  • AlphaCentric Advisors bought 24 Humana shares in Q3 2026, an estimated $9.33K.
  • Humana made up 0.11% of AlphaCentric Advisors's portfolio in Q3 2026, its #201 holding.
  • AlphaCentric Advisors first reported a position in Humana in Q4 2020 and has held it in 10 quarters since.
  • AlphaCentric Advisors's Humana position peaked at $190K in Q2 2023.
  • 802 funds tracked by Wall St. Rank held Humana as of Q3 2026.

Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.